Today is celebrated the “World Cancer Day” and I want to tell you about the recent advances against the colon cancer.
The Doctor Javier Rodríguez belongs to the Department of Medical Oncology, in the University of Navarra (North-east of Spain).He talks about colon cancer in a video that I want to show you.Please click down here (on the video in the website) and after I will translate his words for you:
http://www.abc.es/videos-abcsalud/20121113/ultimos-avances-contra-cancer-1964578961001.html
"Thanks to advances in molecular biology and genetic knowledge of colorectal cancer, the disease has undergone a major transformation in recent years, mostly aimed at trying to individualize treatment for each development patient. There are several lines that seem very promising, which could be summarized as follows: the first is the interaction between the pharmacokinetics and genomical. We know that drugs act at different levels and achieve an optimal dose for each patient, has shown much improved chance of improvement and survival of them. The genetic analysis at our disposal allow individualized dose for each person, so as to achieve greater efficiency with lower profile toxicity. There are several studies that support this type of strategy, with which is able to optimize the results of drugs so far available.
The second line of development would go through the discovery of "therapeutic targets." This has allowed us to find points that are important for the development of cells that are lockable, pharmacologically, which has greatly expanded the range of drugs available to us , so that not only are chemotherapy drugs, but increasingly more importance is given to the development of so-called "biologic drugs"., which have several advantages: its tolerance is very good; the side effect profile is very mostly small, which enhance the effectiveness of some chemotherapy drugs.
Furthermore, as a novel strategy is known today, that colorectal cancer is a tumor immunegenic. In the recent years begins to raise ways to stimulate the immune system to fight it's own tumor. There are preliminary data, very promising, regarding strategies that stimulate the immune system and result in an increased likelihood of improvement and in a longer time, in the control of disease.
In our Hospital, we have two studies , raised in vaccines, along with chemotherapy, with the idea that interaction between conventional drugs and immune system activation translate into better results in the medium and long term.
And finally, today generally arises continuing care strategy for patients with metastatic colon cancer, enabling both quality of life and survival are as long as possible".
I want to send a message of hope to all the patients.
Kind regards,
Luis.
Sponsored by Costaluz Lawyers.
Please click down here:
.jpg)